Lido Advisors »

Galectin Therapeutics shares owned by Lido Advisors

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Lido Advisors from 13F filings

Historical chart of Lido Advisors investment in Galectin Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by Lido Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by Lido Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $154k 36k 4.24
2025-03-31 $19k 15k 1.22

More positions owned by Lido Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Apple (AAPL)
Invesco Exch Trd Slf Idx Bulshs 2027 Cb (BSCR)
Microsoft Corporation (MSFT)
NVIDIA Corporation Put Option (NVDA)
Invesco Exch Trd Slf Idx Bulshs 2026 Cb (BSCQ)
Invesco Exch Trd Slf Idx Bulshs 2025 Cb (BSCP)
Fidelity Covington Trust Msci Info Tech I (FTEC)
Ishares Tr S&p 500 Grwt Etf (IVW)
Amazon (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr S&p 500 Val Etf (IVE)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)

View all positions for Lido Advisors

Top funds holding Galectin Therapeutics

Vanguard Group
Advisor Group Holdings
BlackRock
Geode Capital Management
Susquehanna International
Marshall Wace
Sontag Advisory
LPL Financial
Geneos Wealth Management
Commonwealth Equity Services
Vivaldi Capital Management
State Street Corporation
Morgan Stanley
Retirement Guys Formula
Sovran Advisors

View all funds holding Galectin Therapeutics